Gripum loses its bid to overturn FDA marketing denial…

US – general: Illinois-based e-liquid manufacturer Gripum’s petition for a review of its marketing denial order (MDO), filed on 8th October 2021 in the Seventh Circuit Court of Appeals, has been denied. The court found that the Food and Drug Administration (FDA)’s denial of the company’s premarket tobacco product application (PMTA) for a range of flavoured liquids was not arbitrary or » Continue Reading. ...